<code id='DE22C0A578'></code><style id='DE22C0A578'></style>
    • <acronym id='DE22C0A578'></acronym>
      <center id='DE22C0A578'><center id='DE22C0A578'><tfoot id='DE22C0A578'></tfoot></center><abbr id='DE22C0A578'><dir id='DE22C0A578'><tfoot id='DE22C0A578'></tfoot><noframes id='DE22C0A578'>

    • <optgroup id='DE22C0A578'><strike id='DE22C0A578'><sup id='DE22C0A578'></sup></strike><code id='DE22C0A578'></code></optgroup>
        1. <b id='DE22C0A578'><label id='DE22C0A578'><select id='DE22C0A578'><dt id='DE22C0A578'><span id='DE22C0A578'></span></dt></select></label></b><u id='DE22C0A578'></u>
          <i id='DE22C0A578'><strike id='DE22C0A578'><tt id='DE22C0A578'><pre id='DE22C0A578'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:379
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

          Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

          advertisement

          STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          As health system earnings go up, health insurance stocks go down
          As health system earnings go up, health insurance stocks go down

          AdobeAmericans,especiallyMedicarebeneficiaries,aregettingmoremedicalcarethesedays.DemandfromagingBab

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

          17:55UkrainianPresidentVolodymyrZelenskyyspeakswithABCNews'MarthaRaddatz.YuriyBoyko/ABCNewsKYIV,Ukra